Singapore Markets open in 1 hr 10 mins
  • Straits Times Index

    3,220.98
    +47.05 (+1.48%)
     
  • S&P 500

    3,997.51
    -5.36 (-0.13%)
     
  • Dow

    32,470.03
    -90.57 (-0.28%)
     
  • Nasdaq

    11,868.80
    +8.69 (+0.07%)
     
  • BTC-USD

    27,303.86
    -798.29 (-2.84%)
     
  • CMC Crypto 200

    615.59
    -0.36 (-0.06%)
     
  • FTSE 100

    7,566.84
    +30.62 (+0.41%)
     
  • Gold

    1,951.80
    +10.70 (+0.55%)
     
  • Crude Oil

    70.41
    +0.74 (+1.06%)
     
  • 10-Yr Bond

    3.5560
    -0.0500 (-1.39%)
     
  • Nikkei

    27,466.61
    +520.94 (+1.93%)
     
  • Hang Seng

    19,591.43
    +332.67 (+1.73%)
     
  • FTSE Bursa Malaysia

    1,412.04
    +5.49 (+0.39%)
     
  • Jakarta Composite Index

    6,691.61
    +79.12 (+1.20%)
     
  • PSE Index

    6,546.27
    +15.52 (+0.24%)
     

Is Gilead Sciences Stock a Screaming Buy After Its Strongest Results in 7 Years?

Is Gilead Sciences Stock a Screaming Buy After Its Strongest Results in 7 Years?

Despite a slower start this year, Gilead appears to be in pretty good shape to resume its momentum. CEO Dan O'Day stated in the press release announcing the numbers, "2022 marked Gilead's strongest full-year growth in our base business since HCV sales peaked in 2015." Is Gilead Sciences stock a buy after its strongest results in seven years?